HCW Biologics targets first-half 2027 IND filing for solid-tumor candidate on October 13, 2026 Application procedure Biological Factors First-in-Human Study HCW HCW11 Indonesian language Solid Neoplasm T-cell engager Type B meeting United States Food and Drug Administration +